MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Stem cells obtained from a patient's own adipose tissue for MS treatment

Back to neurology news Blogs list Cancer blog  


Subscribe To Neurology News RSS Feed  RSS content feed What is RSS feed?

Stem cells obtained from a patient's own adipose tissue for MS treatment




A preliminary study on the use of stem cells obtained from a patient's own adipose tissue in the therapy of multiple sclerosis (MS) has shown promising results. The three case studies, described in BioMed Central's open access Journal of Translational Medicine support further clinical assessment of stromal vascular fraction (SVF) cells in MS and other autoimmune conditions.



Stem cells obtained from a patient's own adipose tissue for MS treatment

Thomas Ichim, from Medistem Inc., and Dr. Boris Minev, from the Division of Neurosurgery, University of California San Diego, worked with a team of scientists to demonstrate the possible effectiveness of SVF cells in MS therapy. Minev said, "All three patients in our study showed dramatic improvement in their condition after the course of SVF treatment. While obviously no conclusions in terms of therapeutic efficacy can be drawn from these reports, this first clinical use of fat stem cells for therapy of MS supports further investigations into this very simple and easily-implementable therapy methodology".

MS is an autoimmune condition, in which the body's own defences attack nerve cells, resulting in loss of their fatty myelin sheath. The first symptoms commonly occur in young adults, most usually in women. It is believed that SVF cells, and other stem cells, appears to be able to treat the condition by limiting the immune reaction and promoting the growth of new myelin. As per Minev, "None of the presently available MS therapys selectively inhibit the immune attack against the nervous system, nor do they stimulate regeneration of previously damaged tissue. We've shown that SVF cells may fill this therapeutic gap".

Minev and colleagues provided the SVF therapy to three patients with MS. The first had suffered frequent painful seizures for the prior three years; after therapy he reported that the seizures had stopped completely and that he had seen significant improvements in his cognition and a reduction of spasticity in his arms and legs. The second patient reported improvements in his sense of balance and coordination, as well as an improved energy level and mood. The final patient had been diagnosed with MS in 1993. After SVF therapy in 2008, his gait, balance and coordination improved dramatically over a period of several weeks. As per Minev, "His condition continued to improve over the next few months and he is currently reporting a continuing improvement and ability to jog, run and even bicycle".


Posted by: Daniel    Source




Did you know?
A preliminary study on the use of stem cells obtained from a patient's own adipose tissue in the therapy of multiple sclerosis (MS) has shown promising results. The three case studies, described in BioMed Central's open access Journal of Translational Medicine support further clinical assessment of stromal vascular fraction (SVF) cells in MS and other autoimmune conditions.

Medicineworld.org: Stem cells obtained from a patient's own adipose tissue for MS treatment

Acute bacterial meningitis| Alzheimer's disease| Carpal tunnel syndrome| Cerebral aneurysms| Cerebral palsy| Chronic fatigue syndrome| Cluster headache| Dementia| Epilepsy seizure disorders| Febrile seizures| Guillain barre syndrome| Head injury| Hydrocephalus| Neurology| Insomnia| Low backache| Mental retardation| Migraine headaches| Multiple sclerosis| Myasthenia gravis| Neurological manifestations of aids| Parkinsonism parkinson's disease| Personality disorders| Sleep disorders insomnia| Syncope| Trigeminal neuralgia| Vertigo|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.